中国社区医师
中國社區醫師
중국사구의사
Chinese Community Doctors
2014年
20期
65-65,67
,共2页
甲亢131I治疗%甲状腺摄碘率%剂量%疗效分析
甲亢131I治療%甲狀腺攝碘率%劑量%療效分析
갑항131I치료%갑상선섭전솔%제량%료효분석
131I treatment of hyperthyroidism%Thyroid iodine uptake%Dose%Curative effect analysis
目的：探讨甲状腺摄碘率＜30%甲亢患者131I的治疗疗效。方法：2009年1月-2011年3月收治经甲亢131I治疗患者844例，将甲状腺摄碘率＜30%的患者作为试验组，而将甲状腺摄碘率＞30%的患者作为对照组进行治疗，并对治疗后的甲亢治愈率和甲减发生率进行分析。结果：在经过6个月的治疗后，两组的甲低发生率和治愈率并无明显的差异。结论：131I治疗适用于低甲状腺摄碘率甲亢患者且疗效显著。
目的：探討甲狀腺攝碘率＜30%甲亢患者131I的治療療效。方法：2009年1月-2011年3月收治經甲亢131I治療患者844例，將甲狀腺攝碘率＜30%的患者作為試驗組，而將甲狀腺攝碘率＞30%的患者作為對照組進行治療，併對治療後的甲亢治愈率和甲減髮生率進行分析。結果：在經過6箇月的治療後，兩組的甲低髮生率和治愈率併無明顯的差異。結論：131I治療適用于低甲狀腺攝碘率甲亢患者且療效顯著。
목적：탐토갑상선섭전솔＜30%갑항환자131I적치료료효。방법：2009년1월-2011년3월수치경갑항131I치료환자844례，장갑상선섭전솔＜30%적환자작위시험조，이장갑상선섭전솔＞30%적환자작위대조조진행치료，병대치료후적갑항치유솔화갑감발생솔진행분석。결과：재경과6개월적치료후，량조적갑저발생솔화치유솔병무명현적차이。결론：131I치료괄용우저갑상선섭전솔갑항환자차료효현저。
Objective:To investigate the efficacy of 131I in the treatment of hyperthyroidism patients whose iodine uptake rate<30%.Methods:844 cases with hyperthyroidism who had 131I therapy were selected from January 2009 to March 2011.The thyroid iodine uptake rate<30% patients as the experimental group.The thyroid iodine uptake rate>30% patients as the control group. We analyzed the cure rate of hyperthyroidism and the occurrence rate of hypothyroidism after the treatment.Results:After 6 months of treatment,the hypothyroidism occurrence rate and cure rate of two groups had no obvious difference. Conclusion:131I treatment is suitable for low iodine uptake rate of thyroid hyperthyroidism patients and its effect is significant.
